CIBC set a C$18.00 price target on Extendicare (TSE:EXE - Free Report) in a research note issued to investors on Monday,BayStreet.CA reports. The firm currently has an outperform rating on the stock.
Other analysts also recently issued reports about the stock. National Bank Financial upgraded shares of Extendicare to a "strong-buy" rating in a research report on Wednesday, July 16th. National Bankshares raised their target price on shares of Extendicare from C$15.45 to C$16.10 and gave the stock an "outperform" rating in a report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of C$14.92.
Get Our Latest Research Report on Extendicare
Extendicare Price Performance
TSE EXE traded up C$0.23 on Monday, hitting C$14.30. 92,272 shares of the company were exchanged, compared to its average volume of 179,762. The company has a market cap of C$1.20 billion, a P/E ratio of 14.82 and a beta of 0.85. The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02. Extendicare has a 1-year low of C$8.96 and a 1-year high of C$15.24. The firm has a 50 day moving average of C$13.02 and a two-hundred day moving average of C$13.45.
Extendicare Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Monday, September 15th. Shareholders of record on Monday, September 15th were given a $0.042 dividend. This represents a $0.17 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date was Friday, August 29th. Extendicare's payout ratio is currently 50.57%.
Extendicare Company Profile
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
See Also

Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.